CONNECT WITH US
HealthTech

HealthTech

A cancer drug is being touted online as a way to grow taller—what you need to know

Medical Xpress logo

Published on

Add as a preferred source on Google
A cancer drug is being touted online as a way to grow taller—what you need to know

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

A cancer drug linked to rapid growth spurts in children has caught the attention of teenagers looking to gain an extra few inches in height.

Erdafitinib, a medicine designed to treat advanced cancer, has been linked to extraordinary growth spurts in children receiving treatment for brain tumors. Reports of these effects have fueled interest among people seeking to maximize their height—so-called "heightmaxxing," though it's unclear how many are actually taking the drug. However, the trend is visible enough online that TikTok has banned some accounts from promoting it.

However, the same treatment that appears to stimulate height can also interfere with normal skeletal development, potentially causing permanent damage.

Erdafitinib is a targeted cancer drug approved for treating certain patients with advanced bladder cancer. It is also used experimentally for certain types of brain tumor in children. It blocks a family of proteins called fibroblast growth factor receptors, or FGFRs.

These receptors act like molecular switches, controlling how cells grow, divide and survive. In some cancers, genetic changes leave these switches permanently on, causing cells to multiply uncontrollably. Erdafitinib interferes with these signals, slowing cancer cell growth.

Unlike conventional chemotherapy, which affects many rapidly dividing cells, targeted therapies are designed to interfere with specific molecular pathways. But these pathways are rarely exclusive to cancer.

FGFRs also work in healthy tissues, including the eyes, skin and, crucially, developing bones.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.